Mycoplasma Pneumoniae Antigen Detection

Function

Mycoplasma pneumoniae is a unique bacterium that lacks a cell wall, making it naturally resistant to many common antibiotics like penicillin. It is a leading cause of upper and lower respiratory tract infections. Antigen detection tests use antibodies to identify specific proteins (antigens) of the bacteria directly from respiratory secretions.

Why it is Ordered

This test is ordered when a patient presents with symptoms of 'walking pneumonia,' such as a persistent dry cough, fever, headache, and malaise. Because M. pneumoniae grows very slowly in culture (taking up to 3 weeks), antigen detection or PCR-based methods are preferred for rapid diagnosis to initiate appropriate macrolide or tetracycline therapy.

Associated Conditions

• Community-Acquired Pneumonia (CAP): Often seen in school-aged children and young adults.
• Tracheobronchitis: Inflammatory condition of the windpipe and bronchi.
• Extrapulmonary Complications: In rare cases, it can cause skin rashes (Stevens-Johnson syndrome) or neurological issues.

Clinical Management

Rapid identification is crucial for public health, as Mycoplasma outbreaks are common in crowded environments like dormitories or barracks. Since the bacteria lacks a cell wall, identifying it early ensures the doctor does not waste time prescribing ineffective beta-lactam antibiotics.